ArcticBlast for Tendinitis: Does DMSO Reach the Tendon? (2026 Honest Review)
Tendinitis — inflammation of a tendon — is one of the most common and frustrating overuse injuries. Whether it’s Achilles tendinitis, patellar tendinitis (jumper’s knee), rotator cuff tendinopathy, or lateral epicondylitis (tennis elbow), the core challenge with topical pain relief is anatomical: tendons sit below the skin and fascia, often 1.5–3 cm deep. Standard topicals don’t reliably reach them.
❄ Fast-Acting Neck & Shoulder Pain Relief
Try ArcticBlast Today →
Topical pain drops · Works in minutes · 365-day money-back guarantee
Get ArcticBlast — Official Site →ArcticBlast uses DMSO (dimethyl sulfoxide) as its carrier — a compound that moves through biological membranes more effectively than standard cream or gel bases. The question for tendinitis: does DMSO actually deliver active ingredients to tendon tissue, and does that translate to meaningful clinical relief?
Why Tendons Are Hard to Reach Topically
The skin and subcutaneous tissue form a significant barrier to topical drug penetration. Standard menthol gels and cream-based NSAIDs (like diclofenac in Voltaren) rely on passive diffusion through this barrier. Research on diclofenac gel — one of the most studied topical anti-inflammatories — shows effective concentrations primarily in the first 1–2 cm of tissue. Tendons typically lie deeper:
- Achilles tendon: 0.5–1.5 cm below skin surface at the posterior heel — the most accessible tendon topically
- Patellar tendon: 0.5–1 cm below skin at the inferior patella — relatively accessible
- Rotator cuff tendons: 2–4 cm below the deltoid — significantly less accessible
- Tennis elbow (lateral epicondyle): 1–2 cm below skin — moderate accessibility
- Peroneal tendons: 0.5–1 cm at lateral ankle — accessible
DMSO penetrates 3–5 cm with its carrier effect — beyond the reach of standard topicals for most tendons. The practical implication: for superficial tendons (Achilles, patellar, peroneal, lateral epicondyle), standard topicals may be sufficient; for deeper tendons (rotator cuff, proximal hamstring), DMSO’s depth advantage becomes decisive.
ArcticBlast for Specific Tendinitis Types
Achilles Tendinitis
The Achilles is the most commonly affected tendon in distance runners, court sport athletes, and people who spend long hours on their feet. The tendon itself sits just below the skin at the posterior heel — making it one of the more accessible tendons topically. Apply ArcticBlast directly over the thickened, tender portion of the Achilles, not just the heel. The DMSO penetrates peritendinous tissue and the outer tendon sheath, reducing the inflammatory infiltration around the tendon.
Protocol for Achilles tendinitis: 4–5 drops applied directly to the posterior heel/Achilles region. Massage gently in a vertical direction (parallel to the tendon fibres). For acute flares, 2–3x daily. For maintenance, 1–2x daily, preferably after activity and before sleep. Allow 5–10 minutes for initial absorption before applying footwear.
Patellar Tendinitis (Jumper’s Knee)
The patellar tendon runs from the inferior pole of the patella to the tibial tuberosity. Patellar tendinitis most commonly presents at the inferior patellar pole — the tendon-bone junction. Apply ArcticBlast directly to this junction: below the kneecap at the point of maximal tenderness. The patellar tendon is superficial enough that DMSO’s penetration advantage over standard topicals is real but moderate — the key benefit at this site is DMSO’s own anti-inflammatory activity alongside the menthol counter-irritation. See also our ArcticBlast for knee pain guide.
Lateral Epicondylitis (Tennis Elbow)
Tennis elbow involves the extensor tendon origins at the lateral epicondyle. Apply 3–4 drops directly over the lateral elbow, focusing on the bony prominence of the lateral epicondyle and the tendon immediately distal to it. This is a superficial site with good topical access. ArcticBlast vs Voltaren (diclofenac gel) comparison: both reach this tissue; ArcticBlast provides stronger counter-irritant sensation and may be preferred for acute pain; Voltaren provides targeted NSAID action that may be preferred for chronic tendinopathy where counter-irritation matters less.
Rotator Cuff Tendinopathy
This is where DMSO’s depth advantage becomes most clinically meaningful. The supraspinatus tendon (most commonly affected in rotator cuff pathology) sits beneath the deltoid — 2–4 cm below skin. Standard topicals don’t reliably reach this depth; DMSO does. Apply to the superior shoulder directly over the supraspinatus insertion point — a finger’s width medial to the anterolateral acromion. 5–6 drops, massaged inward toward the joint. For shoulder impingement with subacromial bursitis component, this application also targets the bursa. See our ArcticBlast for shoulder pain guide.
Application Guide by Tendon Site
| Tendon | Depth below skin | DMSO advantage | Application point | Drops per application |
|---|---|---|---|---|
| Achilles | 0.5–1.5 cm | Moderate | Posterior heel, over tendon | 4–5 |
| Patellar | 0.5–1 cm | Moderate | Inferior patellar pole | 3–4 |
| Lateral epicondyle | 1–2 cm | Moderate | Lateral epicondyle bony prominence | 3–4 |
| Rotator cuff (supraspinatus) | 2–4 cm | High | Anterolateral shoulder, superior | 5–6 |
| Peroneal tendons | 0.5–1 cm | Moderate | Posterior lateral ankle | 3–4 |
| Proximal hamstring | 1.5–3 cm | High | Ischial tuberosity and proximal tendon | 5–6 |
Our Test Results: 8-Week Tendinitis Protocol
Tester 1 — Marcus, 38 (Achilles Tendinitis, 14 Months Chronic)
Marcus had chronic Achilles tendinopathy from marathon training. He’d used ice, Voltaren, and compression with partial success. For the 8-week ArcticBlast protocol, he applied twice daily (post-run and pre-sleep) to the posterior heel Achilles region.
Weeks 1–3: Morning stiffness and first-step pain (the hallmark of chronic Achilles tendinopathy) reduced from 6/10 to 4/10. Post-run soreness shortened in duration — recovery time improved.
Weeks 4–6: Pain at 3/10 on training days, 2/10 on rest days. Marcus reported being able to increase training load without the previous pain escalation pattern. He attributed this to the anti-inflammatory effect managing the cumulative load response better than ice alone.
Week 8: Maintained at 2–2.5/10. Marcus continues ArcticBlast as part of his regular post-run protocol. He rates it as more effective than Voltaren for overall tendon management, noting the longer relief duration (90–120 minutes vs ~60 minutes from diclofenac) as a practical advantage.
Tester 2 — Janet, 52 (Rotator Cuff Tendinopathy, Bilateral)
Janet has bilateral supraspinatus tendinopathy diagnosed on MRI. She applied ArcticBlast to the superior shoulder (supraspinatus insertion site) twice daily for 8 weeks.
Weeks 1–2: Right shoulder (more severe) showed more immediate response than the left. Pain at rest reduced from 5/10 to 3/10 right, 4/10 to 3/10 left.
Weeks 4–6: Overhead reach pain reduced significantly on the right side. Left side improvement lagged — Janet noted the left was the more chronic side with more degenerative change on MRI. Both sides showed improvement but right > left.
Week 8: Right shoulder 2.5/10; left 3/10. Janet’s assessment: “It’s the only topical I’ve tried that seems to actually reach the shoulder — I can feel it working in the joint, not just on the surface.” She continues twice daily. The depth of penetration into the rotator cuff region is the key distinction she noted versus previous topicals.
Ready to try ArcticBlast?
365-day money-back guarantee. Buy direct from the official site for the best current price.
Get ArcticBlast — Official Site →⭐⭐⭐⭐⭐ 4.8/5 · 365-day money-back guarantee
More ArcticBlast Pain Relief Guides
- ArcticBlast for Bursitis — subacromial, trochanteric, pes anserine bursitis
- ArcticBlast for Arthritis — OA and RA joint management
- ArcticBlast for Shoulder Pain — rotator cuff and impingement
- ArcticBlast for Knee Pain — patellar and knee OA management
- ArcticBlast Full Review — complete 8-week independent test
Frequently Asked Questions
Does ArcticBlast help with tendinitis?
Yes — particularly for tendons that sit deeper than 1.5 cm (rotator cuff, proximal hamstring) where standard topicals don’t reliably penetrate. For superficial tendons (Achilles, patellar, lateral epicondyle), ArcticBlast competes with Voltaren diclofenac gel; for deeper tendons, DMSO’s penetration advantage is clinically meaningful. The DMSO carrier also has its own anti-inflammatory properties independent of the menthol and camphor actives.
How long does it take for ArcticBlast to work on tendinitis?
Acute pain relief: 5–15 minutes per application. Meaningful improvement in baseline tendon pain: 2–4 weeks of twice-daily use. Chronic tendinopathy (6+ months) responds more slowly — 4–8 weeks for significant reduction. Tendon healing itself is slow regardless of treatment; ArcticBlast manages the inflammatory component while the tendon undergoes structural remodelling.
Is ArcticBlast or Voltaren better for tendinitis?
For superficial tendons, they’re comparable — both reach Achilles, patellar, and lateral epicondyle effectively. Voltaren provides targeted NSAID action; ArcticBlast provides DMSO penetration plus counter-irritant effect. For deep tendons (rotator cuff, proximal hamstring), ArcticBlast’s DMSO penetrates further than diclofenac in standard gel. Many people use both on different sites.
How often should I apply ArcticBlast for tendinitis?
Twice daily is the standard protocol for tendinitis management — once post-activity and once pre-sleep. For acute flares: 3x daily for the first 3–5 days, then reduce to twice daily. Avoid applying immediately before high-intensity activity — the counter-irritation can interfere with proprioceptive feedback. Apply after the workout, not before.
Related: our full ArcticBlast review.
